Search results for: Vaccines
Filter search results
The Publicly Funded Vaccines Market in the UK
1 October 2010
…process differs for vaccines compared to curative pharmaceutical products and the implications of… This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in…
The Value of Vaccines and Taskforces
7 February 2023, 3:00pm
…from vaccines, but following the COVID-19 pandemic and our strong reliance on effective and efficient vaccinations and their accompanying rollouts, are we missing their true value? And if so, how…
Just Published: Systematic Review of Utility Weights Used in Economic Evaluations of Vaccines for Paediatric Infectious Diseases
21 April 2016
This blog reports results of a systematic review of the sources and characteristics of utility weights used in economic evaluations of paediatric vaccines in developed countries. A new study has…
Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?
3 January 2020
Meningococcal disease is a life-threatening infection and can result in severe sequelae. Recent scientific and technical advances have led to the discovery and implementation of novel meningococcal vaccines which have…
Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
1 December 2002
…drugs, vaccines and diagnostics. Achieving the latter is a critical part of a… Improving the health and life expectancy of the populations of the less developed countries of the world…
The Broader Value of Vaccines: The Return on Investment From a Governmental Perspective
1 August 2020
…schedule was selected for a form of fiscal health modelling. The model is intended to complement the regular cost-effectiveness assessment of vaccines from a health-system perspective. The results demonstrate that…
Prevention in the NHS 10 Year Health Plan: Promise, limits, and the path forward
17 September 2025
…resource constraints, and behavioural barriers is exemplified in prevention plans surrounding vaccination. The goal Vaccines alone don’t save lives – vaccination does. Although we have safe and effective vaccines available…
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
…a first-of-its-kind analysis of adult immunisation programmes by the Office of Health Economics (OHE) and commissioned by IFPMA (1), looked at four adult vaccines across ten countries where they are…
Incentives for New Drugs and Vaccines to Tackle Anti-Microbial Resistance
16 May 2017
…mechanisms aim to create incentives by creating viable market demand and/or revenues when new products are approved. Pull incentives are key to stimulating R&D for new antibiotics and vaccines. Push…